Compared with SGLT2 inhibitors (such as dapagliflozin or empagliflozin), both classes offer cardiovascular benefits, low hypoglycaemia risk, and weight loss
Notably, the abundance of AKK was significantly diminished in DB group
This blog post is for informational purposes only and does not constitute medical advice, diagnosis, or treatment
In people with obesity or metabolic dysfunction, this signaling system is often impaired meaning the fullness and satiety signals don't fire the way they should
Some people opt for supplementation to increase levels for specific health or fitness goals, including weight loss, improved endurance, or enhanced recovery